Abstract Details

Title: Evaluation of a novel hazardous Drug Environmental Sampling Kit (DESK) for use in healthcare settings
Authors: Chun-Yip Hon; Andrea Griffiths; Avital Jarus Hakak; Matthew Jeronimo; Desre Kramer; Paul Demers; George Astrakianakis
Session: Emerging Issues in Exposure Assessment - St. David, 18 Oct 2016, 3:15 PM - 4:30 PM

Background & Objectives

Exposure of healthcare workers to hazardous (antineoplastic) drugs is associated with reproductive toxicity and an increased risk of developing cancer.  Determining environmental contamination of hazardous drugs using surface wipes is employed to assess the risk of exposure among healthcare workers.  Our team recently developed wipe sampling and analytical protocols for detecting ten drugs simultaneously from one wipe; however, these protocols were tested under laboratory conditions only.  Our current objective was to evaluate the accuracy and usability of these protocols under working conditions within acute care facilities.

Methods

The sampling supplies were assembled into a kit we describe as the Drug Environmental Sampling Kit (DESK). Using the detailed instructions included with the kit, and an accompanying video, three participants were each asked to collect 30 surface wipe samples from various work surfaces within their hospitals.  After sample collection, participants were asked to complete a brief usability survey.  Quantification of drugs collected on each wipe was determined using HPLC-MS/MS reported in mass per unit area. The analytical method also was evaluated for different validation parameters (e.g. accuracy, repeatability, specificity).

Results

Using the DESK, environmental contamination was detected in all three sites.  This is consistent with the literature where widespread drug contamination has been reported.  Up to five different compounds were found with 5-fluorouracil the most prevalent.  Accuracy of the analytical method was found to be between 94 and 104% for all 10 compounds.  Intra-day precision was found to be between 1 and 5% and inter-day precision was found to be between 2 and 9%. Specificity was very good for the majority of compounds. The stability and limit of detection was consistent with other published surface wipe testing methods.  Although mainly positive, the usability surveys indicated some concerns with collecting the control sample. 

Conclusions

Overall, the DESK protocols were well received. The method validation provided consistent results that met exposure assessment criteria. Feedback suggestions from the usability surveys will be incorporated to improve the next iteration of the DESK.  The validation and usability results support the use of DESK to assess the risk of hazardous drug exposure among healthcare workers in BC and elsewhere.